Fennec Pharmaceuticals's total assets for Q2 2024 were $63.16M, a decrease of -8.72% from the previous quarter. FENC total liabilities were $64.52M for the fiscal quarter, a -2.51% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.